- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.09. | InspireMD adds former Axonics co-founder, CFO to board | ||
| 17.09. | Vivani sets date for neuromod spin-off as focus turns to drug delivery implant | ||
| 17.09. | Sight Sciences reports positive data for Omni surgical system | ||
| 17.09. | Nalu Medical picks up $50M in growth funding | ||
| 16.09. | Staar Surgical's board urges stockholders to approve Alcon acquisition in face of scrutiny | ||
| 16.09. | Dexcom CEO takes temporary leave of absence | ||
| 16.09. | SS Innovations' robot completes pediatric pyeloplasty telesurgery | ||
| 16.09. | Roche wins CE mark for CGM, mySugr integration, presents positive clinical data | ||
| 16.09. | MicroPort Cardio's Alwide Plus balloon catheter wins CE mark | ||
| 16.09. | Medtronic reports more positive automated insulin delivery data | ||
| 16.09. | PaceMate prepares for AI expansion with new exec appointment | ||
| 16.09. | Conavi submits next-gen intravascular imaging system to FDA | ||
| 16.09. | FDA clears accelerated protocol for BrainsWay Deep TMS in depression | ||
| 16.09. | Highridge Medical inks distro deal for PathKeeper surgical navigation system | ||
| 16.09. | Insulet makes CFO change, appoints longtime J&J leader | ||
| 16.09. | Nyxoah files patent infringement countersuit against Inspire Medical | ||
| 16.09. | Medtronic prices $1.8B of senior notes | ||
| 15.09. | BD expands Alaris recall after identifying new potential issue | ||
| 15.09. | Philips removes certain DreamStation CPAP, BiPAP devices in another serious recall | ||
| 15.09. | Microbot Medical to raise over $92M from stock sale | ||
| 15.09. | Medtronic initiates global cardiac pacing study in new patient population | ||
| 15.09. | InBrain Neuroelectronics inks Mayo Clinic BCI collab, plans U.S. expansion | ||
| 15.09. | J&J's Shockwave launches Javelin IVL catheter in Europe | ||
| 15.09. | FDA updates on Boston Scientific defibrillation recall related to 16 deaths | ||
| 15.09. | Novocure earns Japanese approval for tumor-treating fields |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .